Annual EBIT
-$99.22 M
-$12.71 M-14.68%
31 December 2023
Summary:
Immunic annual earnings before interest & taxes is currently -$99.22 million, with the most recent change of -$12.71 million (-14.68%) on 31 December 2023. During the last 3 years, it has fallen by -$50.25 million (-102.62%). IMUX annual EBIT is now -3044.30% below its all-time high of $4.33 million.IMUX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$25.73 M
-$2.91 M-12.76%
30 September 2024
Summary:
Immunic quarterly earnings before interest & taxes is currently -$25.73 million, with the most recent change of -$2.91 million (-12.76%) on 30 September 2024. Over the past year, it has dropped by -$2.16 million (-9.15%). IMUX quarterly EBIT is now -6462.76% below its all-time high of -$392.00 thousand, reached on 31 December 2012.IMUX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$95.80 M
-$2.16 M-2.30%
30 September 2024
Summary:
Immunic TTM earnings before interest & taxes is currently -$95.80 million, with the most recent change of -$2.16 million (-2.30%) on 30 September 2024. Over the past year, it has increased by +$4.40 million (+4.39%). IMUX TTM EBIT is now -3942.28% below its all-time high of -$2.37 million, reached on 30 September 2012.IMUX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMUX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.7% | -9.2% | +4.4% |
| 3 y3 years | -102.6% | -39.9% | -13.9% |
| 5 y5 years | -158.3% | -180.3% | -205.1% |
IMUX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -102.6% | at low | -39.9% | +5.6% | -18.7% | +4.4% |
| 5 y | 5 years | -167.9% | at low | -214.3% | +20.6% | -205.1% | +4.4% |
| alltime | all time | -3044.3% | at low | -6462.8% | +20.6% | -3942.3% | +4.4% |
Immunic EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$25.73 M(+12.8%) | -$95.80 M(+2.3%) |
| June 2024 | - | -$22.81 M(-4.5%) | -$93.65 M(-2.3%) |
| Mar 2024 | - | -$23.88 M(+2.1%) | -$95.85 M(-3.4%) |
| Dec 2023 | -$99.22 M(+14.7%) | -$23.38 M(-0.8%) | -$99.22 M(-1.0%) |
| Sept 2023 | - | -$23.57 M(-5.8%) | -$100.20 M(+3.6%) |
| June 2023 | - | -$25.02 M(-8.2%) | -$96.75 M(+4.8%) |
| Mar 2023 | - | -$27.25 M(+11.9%) | -$92.33 M(+6.7%) |
| Dec 2022 | -$86.52 M(-5.6%) | -$24.36 M(+21.1%) | -$86.52 M(+3.1%) |
| Sept 2022 | - | -$20.12 M(-2.4%) | -$83.88 M(+2.1%) |
| June 2022 | - | -$20.61 M(-3.8%) | -$82.15 M(+1.8%) |
| Mar 2022 | - | -$21.43 M(-1.3%) | -$80.71 M(-11.9%) |
| Dec 2021 | -$91.67 M(+87.2%) | -$21.72 M(+18.1%) | -$91.67 M(+9.0%) |
| Sept 2021 | - | -$18.39 M(-4.1%) | -$84.13 M(+6.1%) |
| June 2021 | - | -$19.17 M(-40.8%) | -$79.29 M(+9.6%) |
| Mar 2021 | - | -$32.39 M(+128.2%) | -$72.34 M(+47.7%) |
| Dec 2020 | -$48.97 M(+32.2%) | -$14.19 M(+4.8%) | -$48.97 M(+14.0%) |
| Sept 2020 | - | -$13.54 M(+10.8%) | -$42.97 M(+11.3%) |
| June 2020 | - | -$12.22 M(+35.6%) | -$38.60 M(-6.7%) |
| Mar 2020 | - | -$9.01 M(+10.1%) | -$41.38 M(+11.8%) |
| Dec 2019 | -$37.03 M(-3.6%) | -$8.19 M(-10.8%) | -$37.03 M(+17.9%) |
| Sept 2019 | - | -$9.18 M(-38.8%) | -$31.40 M(-5.0%) |
| June 2019 | - | -$15.01 M(+221.9%) | -$33.06 M(+6.7%) |
| Mar 2019 | - | -$4.66 M(+82.8%) | -$30.98 M(-24.1%) |
| Dec 2018 | -$38.41 M | -$2.55 M(-76.5%) | -$40.80 M(-23.1%) |
| Sept 2018 | - | -$10.85 M(-16.0%) | -$53.03 M(-3.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | -$12.92 M(-10.9%) | -$54.83 M(+0.7%) |
| Mar 2018 | - | -$14.49 M(-1.9%) | -$54.46 M(+3.4%) |
| Dec 2017 | -$52.66 M(+27.6%) | -$14.78 M(+16.9%) | -$52.66 M(+5.9%) |
| Sept 2017 | - | -$12.64 M(+0.7%) | -$49.70 M(+5.1%) |
| June 2017 | - | -$12.55 M(-1.1%) | -$47.30 M(+6.8%) |
| Mar 2017 | - | -$12.69 M(+7.3%) | -$44.30 M(+7.3%) |
| Dec 2016 | -$41.27 M(-20.8%) | -$11.82 M(+15.5%) | -$41.27 M(+4.9%) |
| Sept 2016 | - | -$10.24 M(+7.3%) | -$39.33 M(-5.1%) |
| June 2016 | - | -$9.55 M(-1.1%) | -$41.43 M(-11.8%) |
| Mar 2016 | - | -$9.66 M(-2.4%) | -$46.96 M(-9.9%) |
| Dec 2015 | -$52.12 M(+3.5%) | -$9.89 M(-19.8%) | -$52.12 M(-7.3%) |
| Sept 2015 | - | -$12.34 M(-18.2%) | -$56.25 M(-0.8%) |
| June 2015 | - | -$15.08 M(+1.8%) | -$56.72 M(+6.5%) |
| Mar 2015 | - | -$14.82 M(+5.7%) | -$53.28 M(+5.8%) |
| Dec 2014 | -$50.34 M(+60.3%) | -$14.02 M(+9.4%) | -$50.34 M(+8.1%) |
| Sept 2014 | - | -$12.81 M(+10.1%) | -$46.57 M(+8.5%) |
| June 2014 | - | -$11.64 M(-2.0%) | -$42.93 M(+11.9%) |
| Mar 2014 | - | -$11.88 M(+15.9%) | -$38.35 M(+7.0%) |
| Dec 2013 | -$31.40 M(+399.4%) | -$10.25 M(+11.8%) | -$35.83 M(+37.9%) |
| Sept 2013 | - | -$9.16 M(+29.8%) | -$25.98 M(+35.4%) |
| June 2013 | - | -$7.06 M(-24.5%) | -$19.18 M(+58.3%) |
| Mar 2013 | - | -$9.36 M(+2287.2%) | -$12.12 M(+338.8%) |
| Dec 2012 | -$6.29 M(-286.6%) | -$392.00 K(-83.5%) | -$2.76 M(+16.5%) |
| Sept 2012 | - | -$2.37 M | -$2.37 M |
| Dec 2011 | $3.37 M | - | - |
FAQ
- What is Immunic annual earnings before interest & taxes?
- What is the all time high annual EBIT for Immunic?
- What is Immunic annual EBIT year-on-year change?
- What is Immunic quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Immunic?
- What is Immunic quarterly EBIT year-on-year change?
- What is Immunic TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Immunic?
- What is Immunic TTM EBIT year-on-year change?
What is Immunic annual earnings before interest & taxes?
The current annual EBIT of IMUX is -$99.22 M
What is the all time high annual EBIT for Immunic?
Immunic all-time high annual earnings before interest & taxes is $4.33 M
What is Immunic annual EBIT year-on-year change?
Over the past year, IMUX annual earnings before interest & taxes has changed by -$12.71 M (-14.68%)
What is Immunic quarterly earnings before interest & taxes?
The current quarterly EBIT of IMUX is -$25.73 M
What is the all time high quarterly EBIT for Immunic?
Immunic all-time high quarterly earnings before interest & taxes is -$392.00 K
What is Immunic quarterly EBIT year-on-year change?
Over the past year, IMUX quarterly earnings before interest & taxes has changed by -$2.16 M (-9.15%)
What is Immunic TTM earnings before interest & taxes?
The current TTM EBIT of IMUX is -$95.80 M
What is the all time high TTM EBIT for Immunic?
Immunic all-time high TTM earnings before interest & taxes is -$2.37 M
What is Immunic TTM EBIT year-on-year change?
Over the past year, IMUX TTM earnings before interest & taxes has changed by +$4.40 M (+4.39%)